-
4
-
-
0033408510
-
-
d) H. M. Greenblath, G. Kryger, T. Lewis, I. Silman, J. L. Sussman, FEBS Lett. 1999, 463, 321-326.
-
(1999)
FEBS Lett
, vol.463
, pp. 321-326
-
-
Greenblath, H.M.1
Kryger, G.2
Lewis, T.3
Silman, I.4
Sussman, J.L.5
-
5
-
-
4544291755
-
-
M. Colombres, J. P. Sagal, N. C. Inestrosa, Curr. Pharm. Des. 2004, 10, 3121-3130.
-
(2004)
Curr. Pharm. Des
, vol.10
, pp. 3121-3130
-
-
Colombres, M.1
Sagal, J.P.2
Inestrosa, N.C.3
-
7
-
-
27144524460
-
-
b) B. M. Trost, W. Tang, F. D. Toste, J. Am. Chem. Soc. 2005, 127, 14785-14803;
-
(2005)
J. Am. Chem. Soc
, vol.127
, pp. 14785-14803
-
-
Trost, B.M.1
Tang, W.2
Toste, F.D.3
-
8
-
-
31544471441
-
-
c) J. Marco-Contelles, M. Carreiras, C. Rodriguez, M. Villarroya, A. G. Garcia, Chem. Rev. 2006, 106, 116-133;
-
(2006)
Chem. Rev
, vol.106
, pp. 116-133
-
-
Marco-Contelles, J.1
Carreiras, M.2
Rodriguez, C.3
Villarroya, M.4
Garcia, A.G.5
-
10
-
-
20544474278
-
-
a) A. H. Lewin, J. Szewczyk, J. W. Wilson, F. I. Carroll, Tetrahedron 2005, 61, 7144-7152;
-
(2005)
Tetrahedron
, vol.61
, pp. 7144-7152
-
-
Lewin, A.H.1
Szewczyk, J.2
Wilson, J.W.3
Carroll, F.I.4
-
11
-
-
0026472718
-
-
b) S. Y. Han, J. E. Sweeney, E. S. Bachean, E. J. Schweiger, G. Porloni, J. T. Coyle, B. M. Davis, M. M. Jouillé, Eur. J. Med. Chem. 1992, 27, 673-687.
-
(1992)
Eur. J. Med. Chem
, vol.27
, pp. 673-687
-
-
Han, S.Y.1
Sweeney, J.E.2
Bachean, E.S.3
Schweiger, E.J.4
Porloni, G.5
Coyle, J.T.6
Davis, B.M.7
Jouillé, M.M.8
-
12
-
-
8644264008
-
-
a) P. Liang, J. Liu, L. Hsin, C. Cheng, Tetrahedron 2004, 60, 11655-11660;
-
(2004)
Tetrahedron
, vol.60
, pp. 11655-11660
-
-
Liang, P.1
Liu, J.2
Hsin, L.3
Cheng, C.4
-
13
-
-
8644234636
-
-
b) P. Liang, L. Hsin, S. Pong, C. Hsu, C. Cheng, J. Chin. Chem. Soc. 2003, 50, 449-456.
-
(2003)
J. Chin. Chem. Soc
, vol.50
, pp. 449-456
-
-
Liang, P.1
Hsin, L.2
Pong, S.3
Hsu, C.4
Cheng, C.5
-
14
-
-
0028950380
-
-
a) P. R. Carly, F. Compernolle, G. J. Hoornaert, Tetrahedron Lett. 1995, 36, 2113-2116;
-
(1995)
Tetrahedron Lett
, vol.36
, pp. 2113-2116
-
-
Carly, P.R.1
Compernolle, F.2
Hoornaert, G.J.3
-
15
-
-
0025908958
-
-
b) L. Meerpoel, G. Deroover, K. J. Van Aken, G. Lux, G. J. Hoornaert, Synthesis 1991, 765-768;
-
(1991)
Synthesis
, pp. 765-768
-
-
Meerpoel, L.1
Deroover, G.2
Van Aken, K.J.3
Lux, G.4
Hoornaert, G.J.5
-
17
-
-
0027310982
-
-
a) J. S. Hon, S. W. Lin, Y. W. Chen, Synth. Commun. 1993, 23, 1543;
-
(1993)
Synth. Commun
, vol.23
, pp. 1543
-
-
Hon, J.S.1
Lin, S.W.2
Chen, Y.W.3
-
18
-
-
0030807654
-
-
b) M. J. Aurell, L. Ceita, R. Mestres, A. Tortajada, Tetrahedron 1997, 53, 10883-10898.
-
(1997)
Tetrahedron
, vol.53
, pp. 10883-10898
-
-
Aurell, M.J.1
Ceita, L.2
Mestres, R.3
Tortajada, A.4
-
19
-
-
35548959813
-
-
Spectroscopic data for compound 10a: 1H NMR (400 MHz, CDCl3, δ, 7.69 (s, 1 H, 3.54 (s, 2 H, 3.29 (dd, J, 8.4, 5.4 Hz, 2 H, 2.85 (s, 3 H, 2.55 (t, J, 7.5 Hz, 2 H, 2.51-2.45 (m, 1 H, 2.36 (s, 3 H, 2.24 (s, 3 H, 2.18-2.12 (m, 2 H, 1.72-1.58 (m, 1 H, 1.57-1.45 (m, 1 H) ppm. 13C NMR (100 MHz, CDCl3, δ, 176.9, 148.6, 147.0, 142.5, 132.8, 131.8, 57.9, 55.9, 48.0, 42.6, 40.0, 30.1, 29.6, 25.5, 19.3 ppm. HRMS: calcd. for C15H21Cl 2N3O 329.1062; found 329.1063. Spectroscopic data for compound 10b: 1H NMR (400 MHz, CDCl3, δ, 7.62 (s, 1 H, 3.46 (s, 2 H, 3.28-3.18 (m, 2 H, 2.92 (s, 3 H, 2.52-2.42 (m, 2 H, 2.35-2.28 (m, 1 H, 2.26 (s, 3 H, 2.18 (s, 3 H, 1.90-1.80 (m, 2 H, 1.76-1.66 (m, 1 H, 1.55-1.40 (m, 3 H) ppm. 13C NMR 100 MHz, CDCl3, δ, 172.9, 148.4, 146.9, 142.7, 132.8, 131.8, 57.7, 5
-
3O 343.1218; found 343.1210.
-
-
-
-
20
-
-
35548976890
-
-
CEM-Discover, CEM Corporation P. O. Box 200 Matthews, NC 28106.
-
CEM-Discover, CEM Corporation P. O. Box 200 Matthews, NC 28106.
-
-
-
-
21
-
-
35548950082
-
-
4 and concentrated under reduced pressure.
-
4 and concentrated under reduced pressure.
-
-
-
-
22
-
-
35548937130
-
-
Spectroscopic data for compound 2a: 1H NMR (400 MHz, CDCl3, δ, 7.24 (s, 1 H, 4.20 (d, J, 14.6 Hz, 1 H, 3.62 (d, J, 14.6 Hz, 1 H, 3.46 (dd, J, 16.3, 9 Hz, 1 H, 3.30 (td, J, 9, 3.4 Hz, 1 H, 3.11-3.05 (m, 1 H, 3.02-2.95 (m, 1 H, 2.92 (s, 3 H, 2.73-2.65 (m, 1 H, 2.47 (s, 3 H, 2.48-2.40 (m, 1 H, 2.29 (s, 3 H, 2.09 (dt, J, 13, 8 Hz, 1 H, 1.85-1.80 (m, 1 H) ppm. 13C NMR 100 MHz CDCl3, δ, 176.6, 158.8, 148.5, 141.9, 130.1, 58.2, 55.1, 54.0, 46.8, 43.9, 32.3, 32.1, 30.1, 18.8 ppm. HRMS: calcd. for C 15H20ClN3O 293.1295; found 293.1297. Spectroscopic data for compound 2b: HRMS: calcd. for C16H 22ClN3O 307.1451; found 307.1448
-
3O 307.1451; found 307.1448.
-
-
-
-
23
-
-
35548950711
-
-
This ring closure was carried out at 80°C for 10 min instead of 100°C for 15 min. At 100°C, compound 2b could not be detected
-
This ring closure was carried out at 80°C for 10 min instead of 100°C for 15 min. At 100°C, compound 2b could not be detected.
-
-
-
-
24
-
-
35548948673
-
-
2 268.0978; found 268.0971.
-
2 268.0978; found 268.0971.
-
-
-
-
25
-
-
35548957097
-
-
4.
-
4.
-
-
-
-
26
-
-
35548992136
-
-
2 321.1244; found 321.1249.
-
2 321.1244; found 321.1249.
-
-
-
-
27
-
-
35548964903
-
-
3O 293.1295; found 293.1293.
-
3O 293.1295; found 293.1293.
-
-
-
-
28
-
-
35548981597
-
-
2 307.1088; found 307.1097.
-
2 307.1088; found 307.1097.
-
-
-
-
29
-
-
33644811612
-
-
G. L. Ellman, K. D. Courtney, V. Andres, R. M. Featherstone, Biochem. Pharmacol. 1961, 7, 88-95.
-
(1961)
Biochem. Pharmacol
, vol.7
, pp. 88-95
-
-
Ellman, G.L.1
Courtney, K.D.2
Andres, V.3
Featherstone, R.M.4
|